Decreased Retinol Binding Protein 4 Concentrations are Associated With Cholesterol Gallstone Disease

Journal of the Formosan Medical Association

Volumn 109, Issue 6, 2010, Pages 422-429

  Wang, Shen Nien ^a,b   Yeh, Yao Tsung ^c   Wang, Sen Teh ^d   Chen, Yi Ling ^e   Chuang, Shih Chang ^b   Ker, Chen Guo ^b   Lee, King Teh ^b  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

adipokine; cholesterol gallstone; insulin resistance; renal function; retinol binding protein 4

Indexed keywords

RETINOL BINDING PROTEIN 4;

ARTICLE; CHOLECYSTECTOMY; CHOLESTEROL STONE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GALLSTONE; HUMAN; INFRARED SPECTROSCOPY; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; CHOLECYSTECTOMY, LAPAROSCOPIC; CHOLECYSTOLITHIASIS; CHOLESTEROL; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALLSTONES; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETINOL-BINDING PROTEINS, PLASMA; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 77953671231     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(10)60073-3     Document Type: Article

References (32)

1. Waki H., and Tontonoz P. Endocrine functions of adipose tissue. Annu Rev Pathol 2 (2007) 31-56
2. Ahima R.S. Adipose tissue as an endocrine organ. Obesity (Silver Spring) 14 (2006) S242-S249
3. Goossens G.H. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 94 (2008) 206-218
4. Inadera H. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci 5 (2008) 248-262
5. Faroogi I.S., Wangensteen T., Collins S., et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 356 (2007) 237-247
6. Maiolino G., Cesari M., Sticchi D., et al. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab 93 (2008) 3333-3340
7. Yang Q., Graham T.E., Mody N., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436 (2005) 356-362
8. Choi S.H., Kwak S.H., Youn B.S., et al. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 93 (2008) 3142-3148
9. Graham T.E., Yang Q., Blüher M., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354 (2006) 2552-2563
10. von Eynatten M., Lepper P.M., Liu D., et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 50 (2007) 1930-1937
11. Petta S., Cammà C., Di Marco V., et al. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1. Hepatology 48 (2008) 28-37
12. Henze A., Frey S.K., Raila J., et al. Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes 57 (2008) 3323-3326
13. Cabré A., Lázaro I., Girona J., et al. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J Intern Med 262 (2007) 496-503
14. Portincasa P., Moschetta A., and Palasciano G. Cholesterol gallstone disease. Lancet 368 (2006) 230-239
15. Liew P.L., Wang W., Lee Y.C., et al. Gallbladder disease among obese patients in Taiwan. Obes Surg 17 (2007) 383-390
16. Chen C.H., Huang M.H., Yang J.C., et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol 21 (2006) 1737-1743
17. Lee K.T., Chang W.T., Huang M.C., and Chiu H.C. Influence of surgeon volume on clinical and economic outcomes of laparoscopic cholecystectomy. Dig Surg 21 (2004) 406-412
18. Marschall H.U., and Einarsson C. Gallstone disease. J Intern Med 261 (2007) 529-542
19. Biddinger S.B., Haas J.T., Yu B.B., et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med 14 (2008) 778-782
20. Wang S.N., Yeh Y.T., Yu M.L., et al. Hyperleptinaemia and hypoadiponectinaemia are associated with gallstone disease. Eur J Clin Invest 36 (2006) 176-180
21. Wang S.N., Yeh Y.T., Yu M.L., et al. Serum adiponectin levels in cholesterol and pigment cholelithiasis. Br J Surg 93 (2006) 981-986
22. Yoo E.H., Oh H.J., and Lee S.Y. Gallstone analysis using Fourier transform infrared spectroscopy (FT-IR). Clin Chem Lab Med 46 (2008) 376-381
23. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
24. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
25. Qi Q., Yu Z., Ye X., et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 92 (2007) 4827-4834
26. Gavi S., Qurashi S., Stuart L.M., et al. Influence of age on the association of retinol-binding protein 4 with metabolic syndrome. Obesity (Silver Spring) 16 (2008) 893-895
27. Salem M.A., el-Habashy S.A., Saeid O.M., et al. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus. Pediatr Diabetes 3 (2002) 37-41
28. Ziegelmeier M., Bachmann A., Seeger J., et al. Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care 30 (2007) 2588-2592
29. Yagmur E., Weiskirchen R., Gressner A.M., et al. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care 30 (2007) 1168-1172
30. Bahr M.J., Boeker K.H., Manns M.P., et al. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis. Clin Endocrinol (Oxf) 70 (2009) 60-65
31. Tacke F., Weiskirchen R., and Trautwein C. Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis. Hepatology 48 (2008) 1724-1725
32. Rudkowska I., and Jones P.J. Polymorphisms in ABCG5/G8 transporters linked to hypercholesterolemia and gallstone disease. Nutr Rev 66 (2008) 343-348